Kringle Pharma, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Additional Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury (NCT07722962) | Kringle Pharma, Inc. | 2026-07-31 |
| Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar (NCT05627648) | Kringle Pharma, Inc. | 2022-12-01 |
| Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury (NCT04475224) | Kringle Pharma, Inc. | 2020-07-13 |
Track Kringle Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.